PFM Health Sciences, LP 13D and 13G filings for Aerie Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 12:39 pm Sale |
2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
PFM Health Sciences, LP | 1,088,566 2.300% |
-1,725,797 (-61.32%) |
Filing |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
PFM Health Sciences, LP | 2,814,363 6.000% |
382,864 (+15.75%) |
Filing |